Which Indian biotechnology company developed the first indigenous mRNA vaccine for COVID-19, with support from DBT and BIRAC?
Gennova Biopharmaceuticals Ltd.
Gennova Biopharmaceuticals Ltd. is correct.
Gennova Biopharmaceuticals, a Pune-based company, developed GEMCOVAC, India's first indigenous mRNA vaccine against COVID-19, with funding support from the Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC) under Mission COVID Suraksha. It received emergency use approval in 2022, and an Omicron-specific version followed in 2023.
Bharat Biotech developed Covaxin, an inactivated whole-virus vaccine. Serum Institute of India manufactured Covishield, a viral-vector vaccine licensed from Oxford-AstraZeneca. Panacea Biotec is known for other vaccines and did not develop the indigenous mRNA COVID-19 vaccine.
Similar Questions
What is the main objective of the ‘Genome India Project’?
Important Questions from Biology, Disease & Bio Technology
What is Guillain-Barré Syndrome (GBS), which has recently seen a surge in cases in Pune, Maharashtra?
Consider the following statements with reference to Lower-sodium salt substitutes (LSSS):
1. Recently, The Department of Nutrition and Food Safety (NFS) of the World Health Organization (WHO) has launched its new guideline on the use of lower-sodium salt substitutes.
2. They can help in reducing the risk of cardiovascular diseases.
3. It may cause a deficiency in sodium.
Which of the above statements is/are correct?
Chronic Wasting Disease (CWD) is classified as a type of prion disease. What is a prion?
Consider the following statements:
Statement-I- A decline in pollinator populations can have a significant impact on global food security.
Statement-II- Approximately 35% of the world's food crops rely on animal pollinators for successful reproduction.
Which one of the following is correct in respect to the above statements?
Recently, Niger has became first African Nation to eliminate which of the following diseases as a public health threat?
